NIH Reminder: The Vertebrate Animals Section (VAS) of the NIH applications should be used to provide a concise description of the procedures on live vertebrate animals. However, per the NIH instructions, the justification for the number of animals, sex, ages, and other biological variables should be described in the Research Strategy. For more information on VAS requirements, including a checklist and detailed instructions, please refer to the Vertebrate Animals Section at the NIH Office for Laboratory Animal Welfare webpage here: https://olaw.nih.gov/guidance/vertebrate-animal-section.htm. 

 

Nature Masterclasses- Professional Development Training for Researchers

Accessing the OUHSC Library Institutional Subscription

Nature Masterclasses provides professional development training for researchers — via online courses and on-demand workshops.  The BHS Library subscribes to an online subscription which is available 24/7, so it’s convenient for the researcher’s schedule.  Periodically, live webinars are offered free to subscribers.

From designing your experiments to advancing your career, Nature Masterclasses offer on-demand courses that cover the whole research cycle, so there is something for everyone, at whatever stage of your career. 

Content includes courses for research design, securing funding, experiment and analyse, write and publish, share and disseminate, develop your career, and work with others.

If you would like to access the OUHSC Nature Masterclasses online (NMO) subscription provided by the library, register using the instructions below.

• Use this link or go to the library's home page and navigate to More Resources à All databases & Resources A-Z à Select the letter N and scroll down to Nature Masterclasses à Click on the link
• You will need to register while on the campus network (or VPN) to create a login. Ignore language to request a quote or buy a subscription, and register using the button in the top right hand corner.
• Once registered you can use your login from anywhere. 
• NOTE:  While on the campus network (or VPN) you will have to login to NMC approximately every 6 months to verify that you are a valid user.  You must have valid OUHSC credentials to continue to use NMC.

 

 

Demystifying Grant Budgets: A Beginner's Guide for Researchers

Presenter: Riana Coetsee, Research Management and Training Consultant

Date: 15 June 2023

Time: 11:00 - 12:00 pm (Central Time)

Registration Link: https://forms.gle/gEjWUKggaemABDZ5A

NOTE: This webinar does not require NMO registration

If you would like to access the OUHSC Nature Masterclasses online (NMO) subscription, register using the instructions below.

• Use this link or go to the library's home page and navigate to More Resources à All databases & Resources A-Z à Select the letter N and scroll down to Nature Masterclasses à Click on the link
• You will need to register while on the campus network (or VPN) to create a login. Ignore language to request a quote or buy a subscription, and register using the button in the top right hand corner.
• Once registered you can use your login from anywhere. 
• NOTE:  While on the campus network (or VPN) you will have to login to NMC approximately every 6 months to verify that you are a valid user.  You must have valid OUHSC credentials to continue to use NMC.

 

 

Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications

·         Cycle II PHF Bridge Grant Program Deadline: July 7, 2023

The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they  meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over  $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques.

IMPORTANT UPDATE: This program can now provide funding for up to $100,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $75,000, used to support the project costs. Guidelines and Application Form are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email  VPR@ouhsc.edu.

 

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

• Chisei Pharmaceuticals is seeking novel targets/therapeutics for respiratory diseases with unmet disease, such as COPD, non-CF bronchiectasis and muco-ciliary dysfunction.  Multiple modalities, including small molecule, RNA-based or peptide based therapeutics and antibodies are of interest.  Out of Scope include asthma and CF-related bronchiectasis, gene therapy and cell therapy approaches, and medical devices, diagnostics and monitoring.  Submission entails a one-page 200-300 word non-confidential brief. (deadline 07/01).   
• A world leading crop science company seeks research related to methods of increasing fatty acid or oil production in annual crops.  Approaches of interest include native genes and pathways that can be changed via traditional breeding or gene editing and transgenes that can be introduced.  Out of scope are genes or pathways of animal origin and plant cultivation conditions (i.e. fertilisers) to increase oil accumulation and altering oil composition in non-terrestrial crops.    Submission entails a one-page 200-300 word non-confidential brief. (deadline 07/10).   

 

 

• Notice of Informational Webinar on PAR-23-145, Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
  (NOT-GM-23-044)
• Notice of Information Regarding Close-Out and Transition Planning for the Newborn Screening Translational Research Network
  (NOT-HD-23-012)
• Notice of Change to RFA-AG-24-002, "Renewal of the Interventions Testing Program (U01 Clinical Trial Not Allowed)"
  (NOT-AG-23-030)
• Notice of Clarification for Inclusion of Wellness-Oriented Programming and Activities for PA-21-151 NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
  (NOT-AT-24-008)
• Notice of Change to the Letters of Intent Due Date for "RFA-DK-22-037: Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed)"
  (NOT-DK-23-029)
• Notice of Change to RFA-HD-24-005 "Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed)"
  (NOT-HD-23-017)
• Notice of Extension of the Due Date of PAR-23-161: "Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)"
  (NOT-TR-23-021)
• Notice of Intent to Publish a Notice of Funding Opportunity for Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed)
  (NOT-NS-23-070)
• Notice of Intent to Publish a Notice of Funding Opportunity for Community-Engaged Health Equity Research in Neuroscience Initiative (R34 Clinical Trial Not Allowed)
  (NOT-NS-23-071)
• Notice of Intent to Publish a Funding Opportunity Announcement for Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)
  (NOT-NS-23-087)
• Notice of Intent to Publish a Funding Opportunity Announcement for Human Virome Project: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed)
  (NOT-RM-23-014)
• Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts (U01 Clinical Trial Not Allowed)
  (NOT-RM-23-015)
• Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Project (HVP) (U24 Clinical Trial Not Allowed)
  (NOT-RM-23-016)
• Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Characterize the Human Virome in Longitudinal, Diverse Cohorts Across the Lifespan (U54 Clinical Trial Not Allowed)
  (NOT-RM-23-017)
• Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
  (NOT-CA-23-070)
• Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups
  (NOT-HL-23-089)
• Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
  (NOT-MH-23-275)
• Notice of Special Interest: Notice of Availability of Administrative Supplements for the NCATS Clinical and Translational Science Award (CTSA) Program
  (NOT-TR-23-020)
   

 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

 

• ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
  (PAR-23-199)
  Application Receipt Date(s): May 25, 2025
• Limited Competition: Collaborative Partnership to Advance Global Health Research (U01 Clinical Trial Not Allowed)
  (PAR-23-203)
  Application Receipt Date(s): September 01, 2023
• Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)
  (PAR-23-214)
  Application Receipt Date(s): October 04, 2023
• Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional)
  (RFA-AG-24-025)
  Application Receipt Date(s): November 03, 2023
• Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional)
  (RFA-AG-24-026)
  Application Receipt Date(s): November 03, 2023
• Limited Competition: National Health and Aging Trends (NHATS) and National Study of Caregiving (NSOC) (U01 Clinical Trial Not Allowed)
  (RFA-AG-24-037)
  Application Receipt Date(s): September 29, 2023
• Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Not Allowed)
  (RFA-AI-23-027)
  Application Receipt Date(s): October 11, 2023
• HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
  (RFA-AT-24-003)
  Application Receipt Date(s): October 02, 2023
• Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)
  (RFA-DK-23-008)
  Application Receipt Date(s): October 18, 2023
• Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
  (RFA-HG-23-017)
  Application Receipt Date(s): Multiple dates, see announcement.
• Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
  (RFA-HG-23-018)
  Application Receipt Date(s): Multiple dates, see announcement.

 

 

Cystic Fibrosis (CF) Foundation: Newborn Screening Improvement Program Award

Description: Applications are now being accepted for the 2023 Screening Improvement Program (SIP) Award for Optimizing the Diagnosis of Infants. The application deadline is July 10, 2023. Please review the SIP Award Policies and Guidelines for full details on the award and instructions for the application process. For questions, contact Marissa Rollins (mrollins@cff.org).

 

HRSA Primary Care Training and Enhancement-Language and Disability Access (PCTE-LDA)

Description: The purpose of the PCTE-LDA program is to develop curricula and to train medical students, physician assistant students, and primary care medical residents to provide high quality primary care services to individuals with limited English proficiency (LEP) and/or individuals with physical disabilities and/or intellectual and developmental disabilities (IDD) with goals of improving health outcomes for these populations. 

Application deadline: 7/3/2023

Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-123

 

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)

Description: Invasive surgical procedures offer the opportunity for unique intracranial interventions such as the ability to record and stimulate intracranially within precisely localized brain structures in humans. Human studies using invasive technology are often constrained by a limited number of patients and available resources, and frequently the resulting datasets need to be aggregated across sites to achieve sufficient statistical power. To overcome these fundamental barriers and to investigate high-impact questions in human neuroscience, this Notice of Funding Opportunity (NOFO) seeks applications to assemble diverse, integrated, multi-disciplinary teams that cross boundaries of interdisciplinary collaboration. The research should be proposed as exploratory research and planning activities to establish feasibility, proof-of-principle and early-stage development that, if successful, would support, enable, and/or lay the groundwork for a potential, subsequent Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain, as described in the companion NOFO (RFA-NS-22-041). Projects should maximize opportunities to conduct innovative in vivo neuroscience research made available by direct access to the brain from invasive surgical procedures. Projects should employ approaches guided by specified theoretical constructs and by quantitative, mechanistic models where appropriate.

Recipients will join a consortium working group, coordinated by the NIH, to identify consensus standards of practice, including neuroethical considerations, to collect and provide data for ancillary studies, and to aggregate and standardize data for dissemination among the wider scientific community.

Letter of Intent deadline: August 22, 2023

Application deadline: 9/22/2023

Link to Full Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-24-001.html

 

DoD Duchenne Muscular Dystrophy Research Program (DMDRP)

• Idea Development Award (IDA)
• Translational Research Award (TRA)

Pre-Application (Letter of Intent) deadline: August 2, 2023
Application deadline: August 23, 2022

Link to Full Announcement: https://cdmrp.health.mil/funding/dmdrp